相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Metal organic frameworks (MOFS) as non-viral carriers for DNA and RNA delivery: a review
Gabriela Soriano-Giles et al.
REVIEWS IN INORGANIC CHEMISTRY (2023)
Synthesis, molecular docking and anticancer potential of azolium based salts and their silver complexes: DNA/BSA interaction studies and cell cycle analysis
Rizwan Ashraf et al.
JOURNAL OF MOLECULAR LIQUIDS (2023)
O -Halogen-substituted arene linked selenium- N -heterocyclic carbene compounds induce significant cytotoxicity: Crystal structures and molecular docking studies
Khizar Hayat et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2023)
Evaluation of Ruthenium(II) N-Heterocyclic Carbene Complexes as Enzymatic Inhibitory Agents with Antioxidant, Antimicrobial, Antiparasitical and Antiproliferative Activity
Ibrahim S. S. Al Nasr et al.
MOLECULES (2023)
Mechanistic, Computational Study of Alkene-Diazene Heterofunctional Cross-Metathesis Catalyzed by Ruthenium Complexes
Magdalena Jawiczuk et al.
ORGANOMETALLICS (2023)
Metal-Organic Frameworks as bio- and heterogeneous catalyst supports for biodiesel production
Yetzin Rodriguez Mejia et al.
REVIEWS IN INORGANIC CHEMISTRY (2023)
Detection of different chemical moieties in aqueous media by luminescent Europium as sensor
Komal Bashir et al.
REVIEWS IN INORGANIC CHEMISTRY (2023)
Surface-enhanced Raman spectral characterization of antifungal activity of selenium and zinc based organometallic compounds
Ali Raza et al.
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY (2023)
The use of metal-organic frameworks as heterogeneous catalysts
Viktoria Larina et al.
REVIEWS IN INORGANIC CHEMISTRY (2023)
Half-Sandwich Ruthenium Arene Complexes Bearing Clinically Approved Drugs as Ligands: The Importance of Metal-Drug Synergism in Metallodrug Design
Chezhiyan Sumithaa et al.
MOLECULAR PHARMACEUTICS (2023)
Cytotoxic, Thrombolytic and Antibacterial Evaluation of Synthesized Substituted and Un-Substituted Selenium-N-Heterocyclic Carbene Adducts
Amna Kamal et al.
JOURNAL OF THE CHEMICAL SOCIETY OF PAKISTAN (2023)
Phototherapeutic anticancer strategies with first-row transition metal complexes: a critical review
Lisa Gourdon et al.
CHEMICAL SOCIETY REVIEWS (2022)
Latest developments in metal complexes as anticancer agents
Renata Paprocka et al.
COORDINATION CHEMISTRY REVIEWS (2022)
Rising Interest in the Development of Metal Complexes in Cancer Immunotherapy
Zhi-Yuan Li et al.
CHEMISTRY-AN ASIAN JOURNAL (2022)
In-vitro anticancer profile of recent ruthenium complexes against liver cancer
Khurram Shahzad et al.
REVIEWS IN INORGANIC CHEMISTRY (2022)
Photoactive and Luminescent Transition Metal Complexes as Anticancer Agents: A Guiding Light in the Search for New and Improved Cancer Treatments
Brondwyn S. McGhie et al.
BIOMEDICINES (2022)
Metal complex-based liposomes: Applications and prospects in cancer diagnostics and therapeutics
Zhaomeng Wang et al.
JOURNAL OF CONTROLLED RELEASE (2022)
Targeting of the intracellular redox balance by metal complexes towards anticancer therapy
Maria Isabel Murillo et al.
FRONTIERS IN CHEMISTRY (2022)
Ruthenium Complexes as Potential Cancer Cell Growth Inhibitors for Targeted Chemotherapy
Snehlata Katheria
CHEMISTRYSELECT (2022)
Potential of Gold Candidates against Human Colon Cancer
Mahvish Abbasi et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2021)
Target based chemotherapeutic advancement of ruthenium complexes
Pragti et al.
COORDINATION CHEMISTRY REVIEWS (2021)
Blue-to-red light triggered nitric oxide release in cytotoxic/cytostatic ruthenium nitrosyl complexes bearing biomimetic ligands
Elena D. Stolyarova et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY (2021)
Cytochrome P450-2D6: A novel biomarker in liver cancer health disparity
Zahraa I. Khamis et al.
PLOS ONE (2021)
Recent advances in the synthesis of (99mTechnetium) based radio-pharmaceuticals
Khurram Shahzad et al.
REVIEWS IN INORGANIC CHEMISTRY (2021)
Metal complexes of β-carboline: Advances in anticancer therapeutics
Yusuf Oloruntoyin Ayipo et al.
COORDINATION CHEMISTRY REVIEWS (2021)
Ruthenium(III) Complexes of NAMI-A Type with Ligands Based on Lonidamine and Bexarotene as Antiproliferative Agents
I. A. Shutkov et al.
RUSSIAN JOURNAL OF INORGANIC CHEMISTRY (2021)
Cytochrome P450-2D6: A novel biomarker in liver cancer health disparity
Zahraa I. Khamis et al.
PLOS ONE (2021)
Synthesis and biological assessment of a ruthenium(II) cyclopentadienyl complex in breast cancer cells and on the development of zebrafish embryos
Golara Golbaghi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Rationally Designed Ruthenium Complexes for Breast Cancer Therapy
Golara Golbaghi et al.
MOLECULES (2020)
Synthesis, physicochemical characterization and biological properties of two novel Cu(II) complexes based on natural products curcumin and quercetin
Eleftherios Halevas et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2020)
Breast Cancer Chemotherapeutic Options: A General Overview on the Preclinical Validation of a Multi-Target Ruthenium(III) Complex Lodged in Nucleolipid Nanosystems
Maria Grazia Ferraro et al.
CELLS (2020)
Automated design and optimization of multitarget schizophrenia drug candidates by deep learning
Xiaoqin Tan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Recent advances in cytotoxicity, cellular uptake and mechanism of action of ruthenium metallodrugs: A review
P. Sudhindra et al.
POLYHEDRON (2020)
Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives
Sang Yeul Lee et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2020)
Heterobimetallic Ru(ii)/Fe(ii) complexes as potent anticancer agents against breast cancer cells, inducing apoptosis through multiple targets
Adriana Pereira Mundim Guedes et al.
METALLOMICS (2020)
Luminescent Ruthenium(II) Polypyridine Complexes for a Wide Variety of Biomolecular and Cellular Applications
Justin Shum et al.
INORGANIC CHEMISTRY (2019)
Biological properties of metal complexes of curcumin
Abolfazl Shakeri et al.
BIOFACTORS (2019)
Estrogens and breast cancer: Mechanisms involved in obesity-related development, growth and progression
Priya Bhardwaj et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2019)
NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry
Enzo Alessio et al.
MOLECULES (2019)
Designing Ruthenium Anticancer Drugs: What Have We Learnt from the Key Drug Candidates?
James P. C. Coverdale et al.
INORGANICS (2019)
The stepwise photodamage of organelles by two-photon luminescent ruthenium(ii) photosensitizers
Kangqiang Qiu et al.
CHEMICAL COMMUNICATIONS (2019)
Nucleus-enriched Ruthenium Polypyridine Complex Acts as a Potent Inhibitor to Suppress Triple-negative Breast Cancer Metastasis In vivo
Xuanhao Zhao et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2019)
Inorganic nanoparticles in diagnosis and treatment of breast cancer
Cristina Nunez et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2018)
Ru(II) Compounds: Next-Generation Anticancer Metallotherapeutics?
Sreekanth Thota et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Therapeutic applications of selenium-derived compounds
Amna Kamal et al.
REVIEWS IN INORGANIC CHEMISTRY (2018)
Applications of Ruthenium Complex in Tumor Diagnosis and Therapy
Ke Lin et al.
FRONTIERS IN PHARMACOLOGY (2018)
Thirty Years of the Drug Candidate NAMI-A and the Myths in the Field of Ruthenium Anticancer Compounds: A Personal Perspective
Enzo Alessio
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2017)
Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives
Tatjana Lazarevic et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
A Review of Ruthenium Complexes Activities on Breast Cancer Cells
Cecilia P. Popolin et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2017)
A Liposome Encapsulated Ruthenium Polypyridine Complex as a Theranostic Platform for Triple-Negative Breast Cancer
Jianliang Shen et al.
NANO LETTERS (2017)
Metal complexes in cancer therapy - an update from drug design perspective
Umar Ndagi et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
The development of ruthenium(II) polypyridyl complexes and conjugates for in vitro cellular and in vivo applications
Fergus E. Poynton et al.
CHEMICAL SOCIETY REVIEWS (2017)
The development of anticancer ruthenium(II) complexes: from single molecule compounds to nanomaterials
Leli Zeng et al.
CHEMICAL SOCIETY REVIEWS (2017)
Ruthenium-containing P450 inhibitors for dual enzyme inhibition and DNA damage
Ana Zamora et al.
DALTON TRANSACTIONS (2017)
Improving Drug Design: An Update on Recent Applications of Efficiency Metrics, Strategies for Replacing Problematic Elements, and Compounds in Nontraditional Drug Space
Nicholas A. Meanwell
CHEMICAL RESEARCH IN TOXICOLOGY (2016)
Inhibition of signaling between human CXCR4 and zebrafish ligands by the small molecule IT1t impairs the formation of triple-negative breast cancer early metastases in a zebrafish xenograft model
Claudia Tulotta et al.
DISEASE MODELS & MECHANISMS (2016)
Inhibition of cancer cell growth by ruthenium complexes
Joji Iida et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Studying Z-DNA and B- to Z-DNA transitions using a cytosine analogue FRET-pair
Blaise Dumat et al.
NUCLEIC ACIDS RESEARCH (2016)
Ruthenium(II) Complexes with 2-Phenylimidazo[4,5-f][1,10] phenanthroline Derivatives that Strongly Combat Cisplatin-Resistant Tumor Cells
Leli Zeng et al.
SCIENTIFIC REPORTS (2016)
Mitochondrial Ca2+ uptake controls actin cytoskeleton dynamics during cell migration
Julien Prudent et al.
SCIENTIFIC REPORTS (2016)
Three-dimensional and co-culture models for preclinical evaluation of metal-based anticancer drugs
Ekaterina Schreiber-Brynzak et al.
INVESTIGATIONAL NEW DRUGS (2015)
Water-Soluble Ruthenium(II) Complexes with Chiral 442,3-Dihydroxypropyl)-formamide Oxoaporphine (FOA): In Vitro and in Vivo Anticancer Activity by Stabilization of G-Quadruplex DNA, Inhibition of Telomerase Activity, and Induction of Tumor Cell Apoptosis
Zhen-Feng Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Ruthenium complexes of ferrocene mannich bases: DNA/BSA interactions and cytotoxicity against A549 cell line
Pulipaka Ramadevi et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY (2015)
Comparison Between Polypyridyl and Cyclometalated Ruthenium(II) Complexes: Anticancer Activities Against 2D and 3D Cancer Models
Huaiyi Huang et al.
CHEMISTRY-A EUROPEAN JOURNAL (2015)
Breast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and Technologies
Mohamed I. Nounou et al.
BREAST CANCER-BASIC AND CLINICAL RESEARCH (2015)
Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models
Yihao Li et al.
BREAST CANCER RESEARCH (2015)
Cellular responses of BRCA1-defective and triple-negative breast cancer cells and in vitro BRCA1 interactions induced by metallo-intercalator ruthenium(II) complexes containing chloro-substituted phenylazopyridine
Tidarat Nhukeaw et al.
BMC CANCER (2014)
Ruthenium(II) complexes as apoptosis inducers by stabilizing c-myc G-quadruplex DNA
Zhao Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
In Vitro and in Vivo Evaluation of Water-Soluble Iminophosphorane Ruthenium(II) Compounds. A Potential Chemotherapeutic Agent for Triple Negative Breast Cancer
Malgorzata Frik et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Modulation of Activity of Known Cytotoxic Ruthenium(III) Compound (KP418) with Hampered Transmembrane Transport in Electrochemotherapy In Vitro and In Vivo
Rosana Hudej et al.
JOURNAL OF MEMBRANE BIOLOGY (2014)
NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
Robert Trondl et al.
CHEMICAL SCIENCE (2014)
Investigation of aromatase inhibitory activity of metal complexes of β-hydroxyquinoline and uracil derivatives
Veda Prachayasittikul et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2014)
Targeting and delivery of platinum-based anticancer drugs
Xiaoyong Wang et al.
CHEMICAL SOCIETY REVIEWS (2013)
The induction of mitochondria-mediated apoptosis in cancer cells by ruthenium(II) asymmetric complexes
Chen Qian et al.
METALLOMICS (2013)
The binding and transport of alternative metals by transferrin
John B. Vincent et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
Ruthenium(II/III)-Based Compounds with Encouraging Antiproliferative Activity against Non-small-Cell Lung Cancer
Eszter M. Nagy et al.
CHEMISTRY-A EUROPEAN JOURNAL (2012)
New Ruthenium(II)-Letrozole Complexes as Anticancer Therapeutics
Annie Castonguay et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Bis(tridentate) Ruthenium-Terpyridine Complexes Featuring Microsecond Excited-State Lifetimes
Douglas G. Brown et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
The DNA damage response and cancer therapy
Christopher J. Lord et al.
NATURE (2012)
Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs
Alberta Bergamo et al.
DALTON TRANSACTIONS (2011)
A phase I dose-escalation study of NKP-1339 in patients with advanced solid tumors refractory to treatment.
N. R. Dickson et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Arene ruthenium complexes as anticancer agents
Georg Suess-Fink
DALTON TRANSACTIONS (2010)
Intracellular protein binding patterns of the anticancer ruthenium drugs KP1019 and KP1339
Petra Heffeter et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2010)
Nuclear Permeable Ruthenium(II)β-Carboline Complexes Induce Autophagy To Antagonize Mitochondrial-Mediated Apoptosis
Caiping Tan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Isolated Seven-Coordinate Ru(IV) Dimer Complex with [HOHOH]- Bridging Ligand as an Intermediate for Catalytic Water Oxidation
Lele Duan et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Hypoxia-induced pathological angiogenesis mediates tumor cell dissemination, invasion, and metastasis in a zebrafish tumor model
Samantha Lin Chiou Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Behavior of H2 chemisorption on Ru/TiO2 surface and its application in evaluation of Ru particle sizes compared with TEM and XRD analyses
Xiongfei Shen et al.
APPLIED CATALYSIS A-GENERAL (2008)
KP1019, A New Redox-Active Anticancer Agent - Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients
Christian G. Hartinger et al.
CHEMISTRY & BIODIVERSITY (2008)
Mixed-ligand Copper(II)-phenolate complexes: Effect of coligand on enhanced DNA and protein binding, DNA cleavage, and anticancer activity
Venugopal Rajendiran et al.
INORGANIC CHEMISTRY (2007)
Targeting cytochrome P450 enzymes: A new approach in anti-cancer drug development
Robert D. Bruno et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
From bench to bedside -: preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)
Christian G. Hartinger et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2006)
Metal-based antitumour drugs in the post genomic era
PJ Dyson et al.
DALTON TRANSACTIONS (2006)
Ruthenium complexes as anticancer agents
I Kostova
CURRENT MEDICINAL CHEMISTRY (2006)
Synthesis, characterization, DNA-binding and photocleavage of complexes [Ru(phen)2(6-OH-dppz)]2+ and [Ru(phen)2(6-NO2-dppz)]2+
XW Liu et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2005)
Taxanes as first-line therapy for advanced non-small cell lung cancer: A systematic review and practice guideline
Q Chu et al.
LUNG CANCER (2005)
Syntheses and DNA-binding studies of two ruthenium(II) complexes containing one ancillary ligand of bpy or phen:: [Ru(bpy)(pp[2,3]p)2](ClO4)2 and [Ru(phen)(pp[2,3]p)2](ClO4)2
BY Wu et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2005)
Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells
S Kapitza et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2005)
Synthesis and structural characterization of Cu(I) and that Ni(II) complexes that contain the bis[2-(diphenylphosphino)phenyl]ether ligand. Novel emission properties for the Cu(I) species
SM Kuang et al.
INORGANIC CHEMISTRY (2002)
Effect of age and single versus multiple dose pharmacokinetics of letrozole (Femara®) in breast cancer patients
CU Pfister et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2001)
A Cu(I) coordination polymer employing a nonsteroidal aromatase inhibitor letrozole as a building block
RX Yuan et al.
JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS (2001)